Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center
- PMID: 36767559
- PMCID: PMC9916218
- DOI: 10.3390/ijerph20032191
Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center
Abstract
Glycogen storage disease (GSD) is a hereditary metabolic disorder caused by enzyme deficiency resulting in glycogen accumulation in the liver, muscle, heart, or kidney. GSD types II, III, IV, and IX are associated with cardiac involvement. However, cardiac manifestation in other GSD types is unclear. This study aimed to describe whether energy deprivation and the toxic effects of accumulated glycogen affect the heart of patients with GSD. We evaluated the left ventricle (LV) wall mass, LV systolic and diastolic function and myocardial strain with conventional echocardiography and two-dimensional speckle-tracking echocardiography (2D STE) in 62 patients with GSD type I, III, VI and IX who visited the Wonju Severance Hospital in 2021. Among the GSD patients, the echocardiographic parameters of 55 pediatrics were converted into z-scores and analyzed. Of the patients, 43 (62.3%), 7 (11.3%) and 12 (19.4%) patients were diagnosed with GSD type I, type III, and type IX, respectively. The median age was 9 years (range, 1-36 years), with 55 children under 18 years old and seven adults over 18 years. For the 55 pediatric patients, the echocardiographic parameters were converted into a z-score and analyzed. Multiple linear regression analysis showed that the BMI z-score (p = 0.022) and CK (p = 0.020) predicted increased LV mass z-score, regardless of GSD type. There was no difference in the diastolic and systolic functions according to myocardial thickness; however, 2D STE showed a negative correlation with the LV mass (r = -0.28, p = 0.041). Given that patients with GSD tend to be overweight, serial evaluation with echocardiography might be required for all types of GSD.
Keywords: cardiac function; global longitudinal strain; glycogen storage disease; left ventricle mass; left ventricle thickness.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.Mol Genet Metab. 2014 Nov;113(3):171-6. doi: 10.1016/j.ymgme.2014.09.005. Epub 2014 Sep 21. Mol Genet Metab. 2014. PMID: 25266922
-
Hepatic ultrasound findings in the glycogen storage diseases.Br J Radiol. 1994 Nov;67(803):1062-6. doi: 10.1259/0007-1285-67-803-1062. Br J Radiol. 1994. PMID: 7820397
-
Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China.Orphanet J Rare Dis. 2025 Jan 28;20(1):41. doi: 10.1186/s13023-025-03570-1. Orphanet J Rare Dis. 2025. PMID: 39875987 Free PMC article.
-
Nutrition therapy for hepatic glycogen storage diseases.J Am Diet Assoc. 1993 Dec;93(12):1423-30. doi: 10.1016/0002-8223(93)92246-t. J Am Diet Assoc. 1993. PMID: 8245377 Review.
-
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.Genes (Basel). 2021 Aug 3;12(8):1205. doi: 10.3390/genes12081205. Genes (Basel). 2021. PMID: 34440378 Free PMC article. Review.
Cited by
-
Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes.Eur J Pediatr. 2025 Aug 9;184(9):540. doi: 10.1007/s00431-025-06371-7. Eur J Pediatr. 2025. PMID: 40781175
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials